Haustermans K - Search Results

1

Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis.

Chys B, Devos G, Everaerts W, Albersen M, Moris L, Claessens F, De Meerleer G, Haustermans K, Briganti A, Chlosta P, Gontero P, Graefen M, Gratzke C, Karnes RJ, Kneitz B, Marchioro G, Salas RS, Spahn M, Tombal B, Van Der Poel H, Walz J, Van Poppel H, Joniau S. Chys B, et al. Among authors: haustermans k. Front Oncol. 2020 Mar 6;10:246. doi: 10.3389/fonc.2020.00246. eCollection 2020. Front Oncol. 2020. PMID: 32211317 Free PMC article.

2

Mucin-secreting adenocarcinoma of the prostate with neuroendocrine differentiation and Paneth-like cells.

Van de Voorde W, Van Poppel H, Haustermans K, Baert L, Lauweryns J. Van de Voorde W, et al. Among authors: haustermans k. Am J Surg Pathol. 1994 Feb;18(2):200-7. doi: 10.1097/00000478-199402000-00010. Am J Surg Pathol. 1994. PMID: 8291659

3

Cell kinetic measurements in prostate cancer.

Haustermans KM, Hofland I, Van Poppel H, Oyen R, Van de Voorde W, Begg AC, Fowler JF. Haustermans KM, et al. Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1067-70. doi: 10.1016/s0360-3016(96)00579-2. Int J Radiat Oncol Biol Phys. 1997. PMID: 9169814

4

Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma.

Van Poppel H, Vandendriessche H, Boel K, Mertens V, Goethuys H, Haustermans K, Van Damme B, Baert L. Van Poppel H, et al. Among authors: haustermans k. J Urol. 1997 Jul;158(1):45-9. doi: 10.1097/00005392-199707000-00013. J Urol. 1997. PMID: 9186320

5

Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer.

Van Poppel H, Tyrrell CJ, Haustermans K, Cangh PV, Keuppens F, Colombeau P, Morris T, Garside L. Van Poppel H, et al. Among authors: haustermans k. Eur Urol. 2005 May;47(5):587-92. doi: 10.1016/j.eururo.2004.12.003. Epub 2004 Dec 30. Eur Urol. 2005. PMID: 15826748 Clinical Trial.

6

The role of whole pelvic radiotherapy in locally advanced prostate cancer.

Dirix P, Haustermans K, Junius S, Withers R, Oyen R, Van Poppel H. Dirix P, et al. Among authors: haustermans k. Radiother Oncol. 2006 Apr;79(1):1-14. doi: 10.1016/j.radonc.2006.03.011. Radiother Oncol. 2006. PMID: 16631267 Review.

7

A pretreatment table for the prediction of final histopathology after radical prostatectomy in clinical unilateral T3a prostate cancer.

Joniau S, Hsu CY, Lerut E, Van Baelen A, Haustermans K, Roskams T, Oyen R, Van Poppel H. Joniau S, et al. Among authors: haustermans k. Eur Urol. 2007 Feb;51(2):388-94; discussion 395-6. doi: 10.1016/j.eururo.2006.06.051. Epub 2006 Jul 14. Eur Urol. 2007. PMID: 16901622

8

Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study.

Junius S, Haustermans K, Bussels B, Oyen R, Vanstraelen B, Depuydt T, Verstraete J, Joniau S, Van Poppel H. Junius S, et al. Among authors: haustermans k. Radiat Oncol. 2007 Aug 8;2:29. doi: 10.1186/1748-717X-2-29. Radiat Oncol. 2007. PMID: 17686162 Free PMC article.

9

[Role of surgery in stade cT3-4 N0M0 prostate cancer].

Van Poppel H, Joniau S, Haustermans K. Van Poppel H, et al. Among authors: haustermans k. Cancer Radiother. 2007 Dec;11(8):483-9. doi: 10.1016/j.canrad.2007.10.003. Cancer Radiother. 2007. PMID: 18198496 French.

10

Evaluating a decision aid for patients with localized prostate cancer in clinical practice.

Isebaert S, Van Audenhove C, Haustermans K, Junius S, Joniau S, De Ridder K, Van Poppel H. Isebaert S, et al. Among authors: haustermans k. Urol Int. 2008;81(4):383-8. doi: 10.1159/000167833. Epub 2008 Dec 10. Urol Int. 2008. PMID: 19077396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

343 results

Search Page